5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms.
作者:
关键词
(±)-8-OH-DPAT(±)-8-hydroxy-2-(di-n-propylamino) tetralin5-HT(1A) agonistsAntidepressantsAntipsychoticsEPSExtrapyramidal symptomsMCMRNMicroinjectionSGASSRISelective serotonin reuptake inhibitor (SSRI)dlSTdorsolateral striatumextrapyramidal symptomsmedial raphe nucleusmotor cortexsecond generation antipsychoticselective serotonin reuptake inhibitor
主题词
动物(Animals);基底神经节疾病(Basal Ganglia Diseases);脑(Brain);男(雄)性(Male);小鼠(Mice);微量注射(Microinjections);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, 血清素, 5-HT1A(Receptor, Serotonin, 5-HT1A);血清素5-HT1受体激动剂(Serotonin 5-HT1 Receptor Agonists);血清素5-HT1受体拮抗剂(Serotonin 5-HT1 Receptor Antagonists)
DOI
10.1016/j.pnpbp.2013.06.016
PMID
23838274
发布时间
2013-09-10
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文